Tumor PDO 2.0
An ALI-based tumor model for studying treatment response alongside source-tissue architecture and immune cells retained from the sample.
CD3CD4CD8
Models & products
Choose the right organoid model and study system
Compare tumor PDOs, normal-tissue organoids and disease models by project goal, available assays and collaboration format. Browse options for supplied models, TRiCBIO-run studies and custom development.
Browse model families
Model type
Model offering
Quick comparisons
Start from a common study combination or select up to three models.
Choosing PDO 1.0 or PDO 2.0Featured models · use the filters to explore the full portfolio
0 of 3 models selected for comparison
Matching models
Human kidney organoids
Assess drug-related kidney injury using morphology, nephron markers and molecular readouts; the culture approach is selected by compound mechanism and priority endpoint.
E-cadherinLRP2Nephrin
Normal lung organoid
Human lung organoids for pulmonary-injury and candidate studies, combining airway and alveolar cell profiling with changes in tissue morphology.
SCGB1A1 (CC10)KRT5LysoTracker / ATII
Adjacent non-tumor liver organoid
Organoids from adjacent non-tumor liver tissue for epithelial-biology, drug-exposure and tumor-versus-adjacent-tissue studies.
CK19
Normal gastric organoid
Study gastric epithelial biology and drug exposure in normal human organoids, with imaging of tissue structure, proliferation and mucin-related markers.
Ki67Mucin-associated IFEpithelial identity
Human endometrial organoid
Track morphology and marker expression from primary establishment and passaging through proliferative, secretory and receptive stages, with epithelial-identity profiling throughout.
E-cadherinKi67ER
Human fallopian tube organoid
Human fallopian tube organoids with serial culture morphology and source-tissue/organoid H&E comparison, plus study-specific identity and functional assays.
H&EMorphologyStudy-specific markers
IBD inflammation and barrier organoid model
For inflammatory bowel disease (IBD), established inflammation and barrier assays in mouse intestinal organoids support candidate comparison across morphology, permeability, viability and F-actin/ZO-1; we tailor a human study to the sample and program goal.
ZO-1F-actin
Breast cancer PDO
Patient-derived breast tumor organoids for single-agent and combination studies, with PDO 2.0 / ALI considered when immune context is relevant.
ERPRKi67
Explore the full model directory
Explore disease and barrier models, filter by organ, study goal or collaboration format, or discuss a tailored program for specialized tissues and functional endpoints.
PRODUCT CATALOG
Organoid products & reagents
PDO 2.0 Recovery & Culture Starter Kit
A starter kit for PDO 2.0 / ALI recovery and initial culture, with protocol guidance and technical support.
- PDO recovery and initial culture
- ALI culture guidance
- Protocol guidance and technical support
ALI Core Culture Kit
Core reagents for teams with ALI experience or preparing to establish a routine PDO 2.0 culture workflow.
- ALI culture
- Tumor tissue-fragment culture
- Tumor–immune organoid research
Primary Establishment & Passaging Kit
For primary sample processing, organoid establishment, expansion and passaging, with gentle dissociation and workflow guidance matched to the sample.
- Primary establishment
- Organoid expansion
- Gentle dissociation and passaging
Organoid Cryopreservation Kit
Configured around model type, cryopreservation scale and post-thaw QC for organoid storage, recovery and biobanking.
- Organoid cryopreservation
- Biobank workflows
- Post-thaw recovery
TME Characterization Antibody Kit
For TME-associated cell profiling by flow cytometry or immunofluorescence, with antibody panels matched to the model and assay platform.
- Flow cytometry
- Immunofluorescence
- TME cell profiling